SCHEMBL8934618

SCHEMBL8934618

COc1cc2c(=O)c(OC)c(-c3ccc(O)cc3)oc2c(OC)c1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.60
ABCG2 Q9UNQ0 3/20 0.60
KDM4E B2RXH2 2/20 0.56
POLB P06746 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
APEX1 P27695 1/20 0.56
RECQL P46063 1/20 0.56
MCL1 Q07820 1/20 0.56
POLH Q9Y253 1/20 0.56
TUBB4A P04350 4/20 0.54
TUBB P07437 4/20 0.54
TUBA3C P0DPH7 4/20 0.54
TUBA1B P68363 4/20 0.54
TUBA4A P68366 4/20 0.54
TUBB4B P68371 4/20 0.54
TUBB3 Q13509 4/20 0.54
TUBB2A Q13885 4/20 0.54
TUBB8 Q3ZCM7 4/20 0.54
TUBA3E Q6PEY2 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29643349 0.88 TUBB4A (0.64) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL24994535 0.80 ABCB1 (0.65) ABCB1ABCG2KDM4EPOLBCYP3A4
SCHEMBL8934506 0.79 TUBB4A (0.79) KDM4EPOLBCYP3A4CYP2D6TUBB4A
SCHEMBL2727281 0.79 ABCG2 (0.83) ABCB1ABCG2KDM4EPOLBCYP3A4
SCHEMBL4135376 0.78 ABCB1 (0.67) ABCB1ABCG2KDM4EPOLBCYP3A4
SCHEMBL31238141 0.77 KDM4E (0.68) ABCB1ABCG2KDM4EPOLBCYP3A4
SCHEMBL7230100 0.76 TUBB4A (0.54) KDM4ETUBB4ATUBBTUBA3CTUBA1B
Calycopterin SCHEMBL2214965 0.76 KDM4E (0.73) ABCB1ABCG2KDM4EPOLBCYP3A4
Penduletin SCHEMBL30823992 0.75 ABCB1 (1.00) ABCB1ABCG2KDM4EPOLBCYP3A4
Penduletin SCHEMBL2217068 0.75 ABCB1 (1.00) ABCB1ABCG2KDM4EPOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed